Swimmer plot of patient outcomes over time for real-world patients with R/R PTCL and CTCL receiving combination duv/romi. Each horizontal bar represents an individual patient’s treatment timeline, with the x-axis denoting time (months since duv/romi treatment initiation) and the y-axis listing individual patients. Colored segments within the bars indicate different responses (blue denotes progression-free and gray denotes progression). Symbols indicate key clinical events (yellow square denotes complete response, dark blue triangle denotes allogeneic HSCT, and green line denotes alive patient status at the time of data cutoff). AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large cell lymphoma; ALK^–, anaplastic lymphoma kinase–negative; ATLL, adult T-cell leukemia/lymphoma; ENKTCL, extranodal natural killer/T-cell lymphoma; GD, gamma-delta; HSTCL, hepatosplenic T-cell lymphoma; MF, mycosis fungoides; SS, Sézary syndrome; w/nTFH, with nodal T follicular helper phenotype.